. Author manuscript; available in PMC: 2023 Jan 5.

Published in final edited form as: Clin Cancer Res. 2022 Aug 2;28(15):3356–3366. doi: 10.1158/1078-0432.CCR-21-2834

Table 2.

Summary statistics of the changed clonotypes throughout chemotherapy.

Changed Clonotypes	Treatment Timeline	CA125 response	Median	90% Median Confidence Interval (CI)
Novel and expanded clonotypes	Baseline to C3	CA125 complete responders	0.026%	0.012% - 0.16%
Novel and expanded clonotypes	Baseline to C3	CA125 incomplete responders	0.0025%	0% - 0.011%
Disappeared and contracted clonotypes	C3 to C6	CA125 complete responders	0.058%	0.0088% - 0.099%
	C3 to C6	CA125 incomplete responders	0.0063%	0.0034% - 0.0082%
	C6 to Post	CA125 complete responders	0.014 %	0.0049% - 0.022%
	C6 to Post	CA125 incomplete responders	0.0016%	0% - 0.0044%